February 14, 2018 / 9:37 AM / 6 days ago

BRIEF-Star Pharmaceutical ‍Expects To Report An Operating Loss For Q4​

Feb 14 (Reuters) - Star Pharmaceutical Ltd:

* ‍EXPECTED TO RECORD A SIGNIFICANT DROP IN ITS REVENUE AND REPORT AN OPERATING LOSS FOR 4Q2017​

* EXPECTED RESULT DUE TO IMPAIRMENT LOSS OF RESEARCH AND DEVELOPMENT PROJECT FUNDS DURING 4Q2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below